119 filings
8-K
XENE
Xenon Pharmaceuticals Inc
19 Apr 24
Departure of Directors or Certain Officers
4:21pm
8-K
XENE
Xenon Pharmaceuticals Inc
8 Mar 24
Other Events
5:27pm
8-K
XENE
Xenon Pharmaceuticals Inc
29 Feb 24
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:10pm
8-K
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
8-K
XENE
Xenon Pharmaceuticals Inc
27 Nov 23
Other Events
7:03am
8-K
wg5 5qhpwwywvufuf1
9 Nov 23
Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences
4:06pm
8-K
lhwtsjlbk0 z6
8 Nov 23
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
p0mzin1j97c8yuk f4
9 Aug 23
Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
oy3mo17pn49xo4j4kur
8 Aug 23
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover
4:07pm
8-K
mjz uok19nc9y7
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
brgcbio83c 7ow84g5y4
9 May 23
Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
muw4xyoa6yfhec2qu8bu
14 Mar 23
Departure of Directors or Certain Officers
4:03pm
8-K
2cjw0oi
8 Mar 23
Other Events
4:25pm
8-K
qbevoym lj
1 Mar 23
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
12:00am
8-K
h78eg i2u7cdsiz
8 Nov 22
Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:07pm
8-K
tcksri
7 Nov 22
Other Events
4:06pm
8-K
q26tole q7zhbjz
9 Aug 22
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
12:00am
8-K
j6u dh7qc
23 Jun 22
Other Events
4:04pm
8-K
llponumz3jb 0di78
21 Jun 22
Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
7:03am
8-K
f2qvui0x6r sn1r0k2g
2 Jun 22
Departure of Directors or Certain Officers
4:03pm